JPRN-C000000007未知未知
A combination of cyclosporine and prednisolone and a combination of methylprednisolone, cyclosporine and prednisolone for steroid-resistant nephrotic syndrome in children: A randomized controlled study - A combination of cyclosporine and prednisolone and a combination of methylprednisolone, cyclosporine and prednisolone : A randomized controlled study(JSKDC02)
Japanese Study Group of Kidney Disease in Children0 个研究点目标入组 90 人开始时间: 2005年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Congenital nephrotic syndrome. 2.Other renal or systemic forms of nephrotic syndrome defined on renal biopsy, clinical features or serology (Henoch-Schönlein nephritis, systemic lupus erythematosus). 3.Medical history of allergy or hypersensitivity reactions to methylprednisolone and cyclosporine. 4.Poorly controlled hypertension. 5.Chronic renal dysfunction. 6.Active infectious disease. 7.Severe liver disfunction. 8.History of cyclosporine administration. 9.Pregnancy. 10.Judged inappropriate for this study by the physicians.
研究者
相似试验
进行中（未招募）
3 期
PSL/CYA therapy for early onset of VKH diseaseVogt-Koyanagi-Harada diseaseJPRN-jRCTs011180031amba Kenichi120
已完成
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada diseaseJPRN-UMIN000017093niversity of Tokyo Graduate School of Medicine120
已完成
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi- Harada disease.Vogt-Koyanagi- Harada diseaseJPRN-UMIN000013373Hokkaido University Graduate School of Medicine120
招募中
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada diseaseJPRN-UMIN000014041Yamaguchi University Hospital120
已完成
不适用
A combination of prednisolone and mizoribine and a combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial prolideration in children:A randomized controlled trial of efficacy and safetyIgA nephropathy in childrenJPRN-C000000363The Japanese Pediatric IgA Nephropathy of Treatment Study Group80